scispace - formally typeset
G

Giuseppe Paolisso

Researcher at Seconda Università degli Studi di Napoli

Publications -  518
Citations -  36557

Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.

Papers
More filters
Journal ArticleDOI

Opposite role of pro-inflammatory alleles in acute myocardial infarction and longevity: results of studies performed in a Sicilian population.

TL;DR: The results support the hypothesis that the genetic background favoring cardiovascular diseases is detrimental to longevity and suggest that the centenarian genetic background may be useful for investigating genetic key components of age‐associated diseases that are characterized by a multifactorial etiology.
Journal ArticleDOI

Long-term effects of moderate protein diet on renal function and low-grade inflammation in older adults with type 2 diabetes and chronic kidney disease

TL;DR: In older adults with type 2 diabetes, long-term effects of an MPD regimen are associated with a significant decline of renal function, proteinuria, low-grade inflammation, and oxidative stress without a change in fat-free mass.
Journal ArticleDOI

Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients.

TL;DR: Evidence that LVH in hypertensive patients is associated with a worsening in nonoxidative glucose metabolism is provided, independently of age, body weight, systolic blood pressure and plasma catechola‐mines levels.
Journal ArticleDOI

The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion.

TL;DR: The present study investigating the effect of a combined insulin + glipizide treatment on the metabolic control and insulin requirements in ten non-obese Type-II diabetic patients with recent secondary failure to sulfonylureas and characterizing the relative contributions of changes in endogenous insulin secretion (C-peptide response) and insulin sensitivity to this effect.